NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Bernstein Liebhard LLP is investigating whether the Board of Directors of American Realty Capital Trust, Inc. ("ARCT" or the "Company") (NASDAQ: ARCT) breached its fiduciary duty to its shareholders in agreeing to sell ARCT to Realty Income Corporation (NYSE:O).

(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO )

Under the terms of the agreement, ARCT shareholders will receive a fixed exchange ratio of 0.2874 Realty Income Corporation shares for each share they own.  The investigation is focused on the potential unfairness of the price to ARCT shareholders and the process by which the ARCT Board of Directors considered and approved the transaction.

If you are interested in discussing your rights as an ARCT stockholder, with no obligation or cost to you, please contact U. Seth Ottensoser at:

(877) 779-1414

or

Ottensoser@bernlieb.com.

Bernstein Liebhard LLP has pursued hundreds of securities, consumer and shareholder rights cases and recovered over $3 billion for its clients.  It has been named to The National Law Journal's "Plaintiffs' Hot List" in each of the last nine years.

Bernstein Liebhard LLP

10 East 40th Street

New York, New York 10016

(877) 779-1414

www.bernlieb.com 

ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP.  The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.  The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

SOURCE Bernstein Liebhard LLP

Copyright 2012 PR Newswire

Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024 Haga Click aquí para más Gráficas Arcturus Therapeutics.
Arcturus Therapeutics (NASDAQ:ARCT)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024 Haga Click aquí para más Gráficas Arcturus Therapeutics.